COVID-19 AND PRIMARY IMMUNODEFICIENCY: ONE-YEAR EXPERIENCE.
作者信息
Al Yazidi Laila S, Al Rawahi Hatem, Al Busaidi Ibrahim, Al Tamemi Salem
机构信息
Department of Child Health, Sultan Qaboos University Hospital, Muscat, Oman.
Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman.
出版信息
J Paediatr Child Health. 2021 Apr;57(4):594. doi: 10.1111/jpc.15433. Epub 2021 Mar 10.
Abstract
摘要
相似文献
1
COVID-19 AND PRIMARY IMMUNODEFICIENCY: ONE-YEAR EXPERIENCE.新冠病毒与原发性免疫缺陷：一年经验
J Paediatr Child Health. 2021 Apr;57(4):594. doi: 10.1111/jpc.15433. Epub 2021 Mar 10.
2
Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?新冠疫情中的原发性免疫缺陷疾病：是易感因素还是保护因素？
Am J Med Sci. 2020 Dec;360(6):740-741. doi: 10.1016/j.amjms.2020.07.027. Epub 2020 Jul 29.
3
Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.新冠疫情对以色列原发性免疫缺陷患者的临床影响较小。
Front Immunol. 2021 Jan 14;11:614086. doi: 10.3389/fimmu.2020.614086. eCollection 2020.
4
Risk Factors Associated with COVID-19 Infected Healthcare Workers in Muscat Governorate, Oman.与阿曼马斯喀特省感染 COVID-19 的医护人员相关的风险因素。
J Prim Care Community Health. 2021 Jan-Dec;12:2150132721995454. doi: 10.1177/2150132721995454.
5
Epidemiology, characteristics and outcome of children hospitalized with COVID-19 in Oman: A multicenter cohort study.在阿曼住院的 COVID-19 患儿的流行病学、特征和结局：一项多中心队列研究。
Int J Infect Dis. 2021 Mar;104:655-660. doi: 10.1016/j.ijid.2021.01.036. Epub 2021 Jan 18.
6
CHILDREN WITH ASTHMA HOSPITALISED WITH COVID-19: MULTICENTRE EXPERIENCE.因新冠病毒肺炎住院的哮喘儿童：多中心经验
J Paediatr Child Health. 2021 Mar;57(3):464-466. doi: 10.1111/jpc.15415. Epub 2021 Feb 27.
7
The Use of Telephone Consultation in Primary Health Care During COVID-19 Pandemic, Oman: Perceptions from Physicians.新冠肺炎疫情期间阿曼初级卫生保健中电话咨询的使用：医生的看法。
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720976480. doi: 10.1177/2150132720976480.
8
Obesity and covid-19: a reflection on the relationship between pandemics.肥胖与新冠疫情：对大流行之间关系的反思。
Rev Gaucha Enferm. 2021 Mar 26;42(spe):e20200216. doi: 10.1590/1983-1447.2021.20200216. eCollection 2021.
9
Primary Immunodeficiency and the Gut.原发性免疫缺陷与肠道
Gastroenterol Clin North Am. 2019 Jun;48(2):199-220. doi: 10.1016/j.gtc.2019.02.004. Epub 2019 Apr 5.
10
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency.帕博利珠单抗用于治疗原发性免疫缺陷所致的进行性多灶性白质脑病。
Neurol Neuroimmunol Neuroinflamm. 2019 Oct 9;6(6):e628. doi: 10.1212/NXI.0000000000000628. Print 2019 Nov.
引用本文的文献
1
COVID-19 vaccination: challenges in the pediatric population.2019冠状病毒病疫苗接种：儿科人群面临的挑战
Front Public Health. 2025 Jan 29;12:1390951. doi: 10.3389/fpubh.2024.1390951. eCollection 2024.
2
SARS-CoV-2 excretion and genetic evolution in nasopharyngeal and stool samples from primary immunodeficiency and immunocompetent pediatric patients.原发性免疫缺陷和免疫功能正常儿科患者鼻咽及粪便样本中新冠病毒的排泄及基因进化
Virol J. 2025 Jan 13;22(1):9. doi: 10.1186/s12985-025-02628-7.
3
Diversity in the Clinical Course and Outcome of COVID-19 in Patients with Different Inborn Errors of Immunity can be Associated with the Type of Error.不同先天性免疫缺陷患者中新冠病毒病临床病程和结局的多样性可能与缺陷类型有关。
Adv Biomed Res. 2024 Nov 30;13:112. doi: 10.4103/abr.abr_134_23. eCollection 2024.
4
Impact of COVID-19 Pandemic on Clinical Care of Patients and Psychosocial Health of Affected Families with Chronic Granulomatous Disease: an Observational Study from North India.COVID-19 大流行对印度北部慢性肉芽肿病患者临床护理和受影响家庭社会心理健康的影响：一项观察性研究。
J Clin Immunol. 2023 Oct;43(7):1483-1495. doi: 10.1007/s10875-023-01524-5. Epub 2023 Jun 6.
5
Severity Outcomes among Adult Patients with Primary Immunodeficiency and COVID-19 Seen in Emergency Departments, United States, April 2020-August 2021.2020年4月至2021年8月在美国急诊科就诊的原发性免疫缺陷合并新冠病毒病成年患者的严重程度结局
J Clin Med. 2023 May 17;12(10):3516. doi: 10.3390/jcm12103516.
6
Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.儿童变态反应性疾病和免疫缺陷，2022 年从 COVID-19 大流行中吸取的教训：EAACI 儿科分会的声明。
Pediatr Allergy Immunol. 2022 Oct;33(10):e13851. doi: 10.1111/pai.13851.
7
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era.德尔塔（B.1.617.2）和奥密克戎（B.1.1.529）变异株流行时期儿童人群中 SARS-CoV-2 感染情况。
Virol J. 2022 Sep 8;19(1):144. doi: 10.1186/s12985-022-01873-4.
8
COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review.原发性免疫缺陷患者的 COVID-19 相关健康结局：系统评价。
Clin Immunol. 2022 Oct;243:109097. doi: 10.1016/j.clim.2022.109097. Epub 2022 Aug 13.
9
COVID-19 and Inborn Errors of Immunity.COVID-19 与先天性免疫缺陷
Physiology (Bethesda). 2022 Nov 1;37(6):0. doi: 10.1152/physiol.00016.2022. Epub 2022 Aug 9.
10
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK.在英国，原发性和继发性免疫缺陷患者感染 SARS-CoV-2 后的结果。
Clin Exp Immunol. 2022 Sep 29;209(3):247-258. doi: 10.1093/cei/uxac008.
本文引用的文献
1
Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency.SARS-CoV-2 大流行对原发性免疫缺陷患者的影响。
J Clin Immunol. 2021 Feb;41(2):345-355. doi: 10.1007/s10875-020-00928-x. Epub 2020 Dec 1.
2
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.先天性免疫缺陷患者的 2019 年冠状病毒病：一项国际研究。
J Allergy Clin Immunol. 2021 Feb;147(2):520-531. doi: 10.1016/j.jaci.2020.09.010. Epub 2020 Sep 24.
3
Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?新冠疫情中的原发性免疫缺陷疾病：是易感因素还是保护因素？
Am J Med Sci. 2020 Dec;360(6):740-741. doi: 10.1016/j.amjms.2020.07.027. Epub 2020 Jul 29.
Zotero 插件